Search for: "Glaxo Operations UK Ltd. v. Quigg"
Results 1 - 7
of 7
Sorted by Relevance
|
Sort by Date
15 Apr 2010, 5:20 am
Cir. 2009) (quoting Glaxo Operations UK Ltd. v. [read post]
31 Oct 2011, 5:40 pm
” In reaching its decision in Photocure, the Federal Circuit relied on its 1990 decision in Glaxo Operations UK Ltd. v. [read post]
10 May 2010, 10:37 am
In contrast, the Federal Circuit’s 1990 decision in Glaxo Operations UK Ltd. v. [read post]
7 Feb 2011, 6:53 pm
The Federal Circuit specifically rejected the PTO’s statutory interpretation and repeated its holding in Glaxo Operations UK Ltd. v. [read post]
10 Nov 2010, 6:22 am
In contrast, the Federal Circuit’s 1990 decision in Glaxo Operations UK Ltd. v. [read post]
19 Jul 2010, 1:12 pm
In contrast, the Federal Circuit’s 1990 decision in Glaxo Operations UK Ltd. v. [read post]
20 May 2010, 7:01 am
Thus the district court held that MAL hydrochloride and ALA hydrochloride are different “products” with different “active ingredients,” as the terms are used in §156, explaining that “a compound can only qualify as the ‘active ingredient’ of a drug if that compound itself is present in the drug,” citing Glaxo Operations UK Ltd. v. [read post]
